Neuralink plans a high-volume rollout of its brain implant technology in 2026, following FDA clearance and a significant $650 million funding boost. The company aims to utilize robotic surgery for implantation, potentially enhancing speed and safety. While proponents view the technology as a vital aid for individuals with disabilities, critics express ongoing concerns regarding long-term safety, ethical implications, and regulatory oversight.